3M Company (MMM) is a Healthcare stock trading at $178.18 (as of 2026-08-20), with a market capitalization of $91.89B and a trailing P/E of 30.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
3M is a diversified technology company with four business segments—Safety and Industrial, Transportation and Electronics, Health Care, and Consumer—producing products such as industrial abrasives and finishing, autobody repair solutions, electrical and adhesive products, and protective equipment. It also offers transportation materials and electronics-related solutions, health care and food safety offerings, and consumer products for worldwide customers.
3M makes and sells a diversified set of technology products, including industrial abrasives and finishing, autobody repair and closure systems, electrical products and materials, adhesives and tapes, and health care and consumer offerings, and it earns money from selling these products across its segments.
3M’s profit model is driven by how product sales across multiple end-markets (Safety and Industrial, Transportation and Electronics, Health Care, and Consumer) translate into segment revenue, with the shown adjusted segment totals also including a Corporate and Other residual.
| SafetyInd | $2.9B |
| TransElec | $1.9B |
| Consumer | $1.1B |
| CorpOther | $0.1B |
Business quality (Strong): The company is structurally diversified across multiple product segments, but the provided segment revenue inputs do not include a separate adjusted Health Care figure that reconciles to total revenue, so investors should verify segment definitions in the source filing.
Valuation: At 31× earnings, MMM trades in line with the Medical Equipment average (32×). Note: one-time items can distort reported P/E.
| Price | $178.18 |
| Market Cap | $91.89B |
| P/E Ratio | 30.7 |
| EV / EBITDA | 16.9 |
| Price / Book | 30.58 |
| Price / Sales | 3.65 |
| Dividend Yield | 1.7% |
| FCF Yield | 4.3% |
| DCF Value (model) | $51.61 |
| DCF Upside vs Price | -71.0% |
| Revenue (TTM) | $24.95B |
| Net Margin | 13.0% |
| Return on Equity | 99.7% |
| Debt / Equity | 4.18 |
| Current Ratio | 1.24 |
| Revenue Growth (YoY) | 2.5% |
| EPS Growth (YoY) | 32.6% |
| FCF Growth (YoY) | -165.7% |
| Altman Z-Score | 4.41 (safe) |
| Piotroski F-Score | 5/9 (moderate) |
| Stock P/E | 30.7 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | 42.0% |
| vs Industry | -6.7% |
| Top Institutional Holder | VANGUARD GROUP INC ($7.85B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 10 |
| Sector | Healthcare |
| Industry | Medical Equipment |
| CEO | William Brown |
| Employees | 61,500 |
| Country | US |
| IPO Date | 1946-01-14 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.